Status:
ENROLLING_BY_INVITATION
Imaging and Gait Analysis in FSHD Patients
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
FSHD - Facioscapulohumeral Muscular Dystrophy
Eligibility:
All Genders
18+ years
Brief Summary
Facioscapulohumeral muscular dystrophy (FSHD) is a common genetic muscle disorder characterized by progressive and often asymmetric muscle weakness, with high variability in clinical severity and dise...
Detailed Description
Facioscapulohumeral muscular dystrophy (FSHD) is a common hereditary myopathy characterized by asymmetric involvement of facial, scapular, truncal, and lower limb muscles. Disease progression is highl...
Eligibility Criteria
Inclusion
- Age ≥ 18 years. Genetically confirmed diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD).
- Availability of:
- Muscle MRI images. 3D Gait Analysis data (with or without personalized orthopedic aids). Both MRI and Gait Analysis performed within a maximum interval of 6 months from each other.
- Regular neurological follow-ups as part of routine clinical care. Signed informed consent for participation in the study.
Exclusion
- Age \< 18 years.
- Unavailability of:
- Muscle MRI images. 3D Gait Analysis data performed within a maximum interval of 6 months from each other.
- Refusal or inability to provide signed informed consent for participation in the study.
Key Trial Info
Start Date :
November 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07164937
Start Date
November 30 2024
End Date
November 30 2026
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UOC Neurologia
Rome, Italy, 00168